US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Estrella Immunopharma

0.9805

+0.02052.14%

Volume:48.60K

Turnover:46.95K

Market Cap:35.46M

PE:-4.04

High:1.01

Open:0.9800

Low:0.9455

Close:0.9600

Loading ...

Overview Company News Filings

Estrella Immunopharma Is Maintained at Buy by D. Boral Capital

Estrella Immunopharma Completes First Dose Group in Non-Hodgkin Lymphoma Study

MT Newswires Live

BRIEF-Estrella Immunopharma Completes First Dose Cohort In Starlight-1 Trial And Receives Approval To Initiate Higher Dose Cohort

Estrella Immunopharma completes first dose cohort in STARLIGHT trial

Estrella Immunopharma Completes First Dose Cohort in Starlight-1 Trial and Receives Approval to Initiate Higher Dose Cohort

THOMSON REUTERS

Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital

Estrella Immunopharma Initiated at Buy by D. Boral Capital

Estrella Immunopharma initiated with a Buy at D. Boral Capital

BRIEF-Estrella Immunopharma Inc - Regains Compliance With Nasdaq Minimum Bid Price Requirement

Estrella Immunopharma Inc - Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS

Estrella Immunopharma files $100M common stock, warrants offering

Estrella Immunopharma : May Offer, Sell up to $100 Mln of Common Stock, Warrants From Time to Time in One or More Transactions

THOMSON REUTERS

BRIEF-Estrella Immunopharma Entered Amendment No. 2 To Common Stock Purchase Agreement Dated April 20, 2023

Estrella Immunopharma-Pursuant to Amendment, Co May Sell and Issue up to $50 Mln of Its Common Stock to White Lion From Time to Time

THOMSON REUTERS

Estrella Immunopharma Inc - Purchase Agreement Term Extended to December 30, 2025

THOMSON REUTERS

Estrella Immunopharma: Entered Amendment No. 2 to Common Stock Purchase Agreement Dated April 20, 2023

THOMSON REUTERS

BRIEF-Estrella Immunopharma Changes Fiscal Year End To December 31

Estrella Immunopharma Inc - Changes Fiscal Year End to December 31

THOMSON REUTERS

Spotlight On US Penny Stocks: Estrella Immunopharma And Two Others To Consider

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ESLA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":0.9805,"timestamp":1745608918691,"preClose":0.96,"halted":0,"volume":48600,"delay":0,"floatShares":9912119,"shares":36165589,"eps":-0.242472,"marketStatus":"Trading","change":0.0205,"latestTime":"04-25 15:22:26 EDT","open":0.98,"high":1.005,"low":0.9455,"amount":46951.73586,"amplitude":0.061979,"askPrice":1.03,"askSize":200,"bidPrice":0.9671,"bidSize":23,"shortable":3,"etf":0,"ttmEps":-0.242472,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745611200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.96,"postHourTrading":{"tag":"盘后","latestPrice":0.96,"preClose":0.96,"latestTime":"16:00 EDT","volume":69,"amount":66.24,"timestamp":1745524801781},"volumeRatio":0.311231},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","floatShares":9912119,"roa":"-35.45%","roe":"-163.06%","lyrEps":-0.121236,"volumeRatio":0.311231,"shares":36165589,"dividePrice":0,"high":1.005,"amplitude":0.061979,"preClose":0.96,"low":0.9455,"week52Low":0.63,"pbRate":"246.71","week52High":3.23,"institutionHeld":0,"latestPrice":0.9805,"committee":-0.793722,"eps":-0.242472,"divideRate":0,"volume":48600,"delay":0,"ttmEps":-0.242472,"open":0.98,"prevYearClose":1.2,"prevWeekClose":0.7936,"prevMonthClose":0.927,"prevQuarterClose":0.927,"fiveDayClose":0.7936,"twentyDayClose":0.93,"sixtyDayClose":1.1723},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESLA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513902012","title":"Estrella Immunopharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2513902012","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513902012?lang=en_us&edition=fundamental","pubTime":"2025-02-22 00:58","pubTimestamp":1740157080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ESLA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 21, 2025 11:58 ET (16:58 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA"],"gpt_icon":0},{"id":"2513924812","title":"Estrella Immunopharma Completes First Dose Group in Non-Hodgkin Lymphoma Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2513924812","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513924812?lang=en_us&edition=fundamental","pubTime":"2025-02-22 00:10","pubTimestamp":1740154215,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma (ESLA) said Friday it has completed the first dose group in its ongoing phase I/II clinical trial evaluating EB103 in adult patients with relapsed/refractory B-cell non-Hodgkin l","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2513129368","title":"BRIEF-Estrella Immunopharma Completes First Dose Cohort In Starlight-1 Trial And Receives Approval To Initiate Higher Dose Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2513129368","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513129368?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:08","pubTimestamp":1740146889,"startTime":"0","endTime":"0","summary":"BRIEF-Estrella Immunopharma Completes First Dose Cohort In Starlight-1 Trial And Receives Approval To Initiate Higher Dose CohortFeb 21 (Reuters) - Estrella Immunopharma Inc ESLA.O:ESTRELLA IMMUNOPHAR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nFWN3PC0YM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2513298026","title":"Estrella Immunopharma completes first dose cohort in STARLIGHT trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2513298026","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513298026?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:55","pubTimestamp":1740146136,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma (ESLA) announced the successful completion of the first dose cohort in its ongoing STARLIGHT-1 Phase I/II clinical trial. Fol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/estrella-immunopharma-completes-first-dose-cohort-in-starlight-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/estrella-immunopharma-completes-first-dose-cohort-in-starlight-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2513260233","title":"Estrella Immunopharma Completes First Dose Cohort in Starlight-1 Trial and Receives Approval to Initiate Higher Dose Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2513260233","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513260233?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:30","pubTimestamp":1740144638,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nFWN3PC0YM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2513298565","title":"Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2513298565","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513298565?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:30","pubTimestamp":1740144600,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., February 21, 2025----Estrella Immunopharma, Inc.  , a clinical stage biopharmaceutical company developing CD19-targeted ARTEMIS T-cell therapies to treat cancer and autoimmune diseases, today announced the successful completion of the first dose cohort in its ongoing STARLIGHT-1 Phase I/II clinical trial. Following a review of safety and efficacy data, the Data and Safety Monitoring Board  has approved the initiation of the second dose cohort, which will administer 5 million receptor-positive T cells per kilogram of body weight of EB103 CD19-Redirected ARTEMIS T-cell therapy.Estrella is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune diseases. Estrella’s mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and other diseases. To accomplish this mission, Estrella’s lead product candidate, EB103, utilizes Eureka’s ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/estrella-immunopharma-completes-first-dose-133000768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ESLAW","BK4139","ESLA"],"gpt_icon":0},{"id":"2512305394","title":"Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2512305394","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512305394?lang=en_us&edition=fundamental","pubTime":"2025-02-20 05:46","pubTimestamp":1740001560,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., February 19, 2025----Estrella Immunopharma, Inc.  , a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancer and autoimmune diseases, today announced that D. Boral Capital LLC , a leading investment bank, has initiated coverage on the Company, assigning a Buy rating to Estrella and established a 12-month price target of $16.00.D. Boral Capital’s analysis focuses on the development of EB103 in B-cell Non-Hodgkin’s Lymphoma, emphasizing Estrella’s ARTEMIS T-cell engineering platform that utilizes cellular mechanisms which closely resemble those of endogenous T-cell receptors, producing a more natural and regulated immune response.The derived 12-month price target of $16.00 underscores market confidence in Estrella’s potential to capture significant market share in immuno-oncology.The models incorporate a 30% probability of success along with a 30% discount rate, reflecting the early stage of Estrella’s clini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/estrella-immunopharma-inc-nasdaq-esla-214600801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ESLA","NDAQ",".IXIC","ESLAW"],"gpt_icon":0},{"id":"2512417151","title":"Estrella Immunopharma Initiated at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2512417151","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512417151?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:21","pubTimestamp":1739881260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ESLA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2025 07:21 ET (12:21 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2512151669","title":"Estrella Immunopharma initiated with a Buy at D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2512151669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512151669?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:16","pubTimestamp":1739881005,"startTime":"0","endTime":"0","summary":"D. Boral Capital analyst Jason Kolbert initiated coverage of Estrella Immunopharma (ESLA) with a Buy rating and $16 price target The firm says Estr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/estrella-immunopharma-initiated-with-a-buy-at-d-boral-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/estrella-immunopharma-initiated-with-a-buy-at-d-boral-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2492464087","title":"BRIEF-Estrella Immunopharma Inc - Regains Compliance With Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2492464087","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492464087?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:04","pubTimestamp":1734383082,"startTime":"0","endTime":"0","summary":"Dec 16 (Reuters) - Estrella Immunopharma Inc   :   * ESTRELLA IMMUNOPHARMA INC - REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENTSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","MNQmain","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NQmain","BK4139","ESLA","SQQQ","NVIW.SI","BK4112","QID","LU2210150020.SGD","USJW.SI","BK4588","TSYW.SI","IE00BKPKM429.USD","USAW.SI","QLD","NDAQ","IE00B64PRP62.GBP","PSQ","TQQQ",".IXIC","BK4585"],"gpt_icon":0},{"id":"2492647746","title":"Estrella Immunopharma Inc - Regains Compliance With Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2492647746","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492647746?lang=en_us&edition=fundamental","pubTime":"2024-12-17 05:01","pubTimestamp":1734382903,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nFWN3NH0QO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2491688093","title":"Estrella Immunopharma files $100M common stock, warrants offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2491688093","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491688093?lang=en_us&edition=fundamental","pubTime":"2024-12-13 06:15","pubTimestamp":1734041711,"startTime":"0","endTime":"0","summary":"17:11 EST Estrella Immunopharma (ESLA) files $100M common stock, warrants offering Published first on TheFly – the ultimate source for real-time, m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/estrella-immunopharma-files-100m-common-stock-warrants-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/estrella-immunopharma-files-100m-common-stock-warrants-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2491350796","title":"Estrella Immunopharma : May Offer, Sell up to $100 Mln of Common Stock, Warrants From Time to Time in One or More Transactions","url":"https://stock-news.laohu8.com/highlight/detail?id=2491350796","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491350796?lang=en_us&edition=fundamental","pubTime":"2024-12-13 06:11","pubTimestamp":1734041504,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nFWN3ND126:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2489235607","title":"BRIEF-Estrella Immunopharma Entered Amendment No. 2 To Common Stock Purchase Agreement Dated April 20, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2489235607","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489235607?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:17","pubTimestamp":1733494674,"startTime":"0","endTime":"0","summary":"Dec 6  - Estrella Immunopharma Inc   :   * ESTRELLA IMMUNOPHARMA: ENTERED AMENDMENT NO. 2 TO COMMON STOCK PURCHASE AGREEMENT DATED APRIL 20, 2023   * ESTRELLA IMMUNOPHARMA-PURSUANT TO AMENDMENT, CO MAY SELL AND ISSUE UP TO $50 MILLION OF ITS COMMON STOCK TO WHITE LION FROM TIME TO TIME   * ESTRELLA IMMUNOPHARMA INC - PURCHASE AGREEMENT TERM EXTENDED TO DECEMBER 30, 2025Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2489423562","title":"Estrella Immunopharma-Pursuant to Amendment, Co May Sell and Issue up to $50 Mln of Its Common Stock to White Lion From Time to Time","url":"https://stock-news.laohu8.com/highlight/detail?id=2489423562","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489423562?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:14","pubTimestamp":1733494456,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nFWN3N71E7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2489235627","title":"Estrella Immunopharma Inc - Purchase Agreement Term Extended to December 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2489235627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489235627?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:14","pubTimestamp":1733494456,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nFWN3N71E7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2489235622","title":"Estrella Immunopharma: Entered Amendment No. 2 to Common Stock Purchase Agreement Dated April 20, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2489235622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489235622?lang=en_us&edition=fundamental","pubTime":"2024-12-06 22:14","pubTimestamp":1733494456,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nFWN3N71E7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2486856368","title":"BRIEF-Estrella Immunopharma Changes Fiscal Year End To December 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2486856368","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486856368?lang=en_us&edition=fundamental","pubTime":"2024-11-27 07:08","pubTimestamp":1732662532,"startTime":"0","endTime":"0","summary":"Nov 26 (Reuters) - Estrella Immunopharma Inc   :   * ESTRELLA IMMUNOPHARMA INC - CHANGES FISCAL YEAR END TO DECEMBER 31Source text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2486685551","title":"Estrella Immunopharma Inc - Changes Fiscal Year End to December 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2486685551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486685551?lang=en_us&edition=fundamental","pubTime":"2024-11-27 06:49","pubTimestamp":1732661354,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nFWN3MX0ZO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2483334609","title":"Spotlight On US Penny Stocks: Estrella Immunopharma And Two Others To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2483334609","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483334609?lang=en_us&edition=fundamental","pubTime":"2024-11-15 04:05","pubTimestamp":1731614737,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences fluctuations, with major indices slipping ahead of anticipated comments from Federal Reserve Chair Jerome Powell, investors are keenly observing potential opportunities. Penny stocks, though often considered a relic of past market eras, continue to offer intriguing possibilities for those willing to explore smaller or newer companies with growth potential. By focusing on strong financials and solid fundamentals, these stocks can present affordable entry points into promising ventures in today's dynamic market landscape.Click here to see the full list of 738 stocks from our US Penny Stocks screener.Overview: Estrella Immunopharma, Inc. is a clinical-stage biopharmaceutical company focused on developing T-cell therapies for blood cancers and solid tumors in the United States, with a market cap of $28.84 million.Operations: Currently, Estrella Immunopharma does not report any revenue segments.Unlock comprehensive insights into our analysis of Estrella ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5ygIe3mPOH0JnEbDLlu8OA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1dccd8cfa328dc3b8a3f5e9d2445d8e6","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5ygIe3mPOH0JnEbDLlu8OA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1dccd8cfa328dc3b8a3f5e9d2445d8e6"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/spotlight-us-penny-stocks-estrella-200537765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","BK4563","ESLAW","BK4526","BK4209","ESLA","ASFH","RLX","BABB","BK4551","BK4139","PHX","SOTK","BK4075","BK4009"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESLA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1739937600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ESLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ESLA","date":"2025-04-24","current":-4.16592,"percent":0.763085,"low":-10.568666,"twenty":-5.633675,"median":-4.661859,"eighty":-4.103527,"high":-3.104323,"avg":-4.966898,"sd":1.188246,"marketCap":36885284},"quantilePoints":[{"date":"2023-10-13","current":-4.972461,"twenty":-6.796753,"median":-5.384194,"eighty":-5.200498,"marketCap":55265934},{"date":"2023-10-20","current":-4.346628,"twenty":-5.624899,"median":-4.845774,"eighty":-4.503973,"marketCap":48310170},{"date":"2023-10-27","current":-4.814103,"twenty":-5.358857,"median":-4.766595,"eighty":-4.395592,"marketCap":53505872},{"date":"2023-11-03","current":-4.877446,"twenty":-5.358857,"median":-4.877446,"eighty":-4.546793,"marketCap":54209897},{"date":"2023-11-10","current":-4.085653,"twenty":-5.257507,"median":-4.829938,"eighty":-4.367404,"marketCap":45409589},{"date":"2023-11-17","current":-3.800607,"twenty":-5.219501,"median":-4.560729,"eighty":-4.142662,"marketCap":42241478},{"date":"2023-11-24","current":-4.914497,"twenty":-5.067477,"median":-4.560729,"eighty":-4.117325,"marketCap":49633737},{"date":"2023-12-01","current":-5.785861,"twenty":-5.257507,"median":-4.829938,"eighty":-4.244012,"marketCap":58434045},{"date":"2023-12-08","current":-4.18255,"twenty":-5.193333,"median":-4.719087,"eighty":-4.244012,"marketCap":42241478},{"date":"2023-12-15","current":-4.356823,"twenty":-5.067477,"median":-4.653087,"eighty":-4.244012,"marketCap":44001540},{"date":"2023-12-22","current":-4.321969,"twenty":-5.053915,"median":-4.560729,"eighty":-4.244012,"marketCap":43649527},{"date":"2023-12-29","current":-4.008277,"twenty":-5.005043,"median":-4.502348,"eighty":-4.203463,"marketCap":40481416},{"date":"2024-01-05","current":-4.043132,"twenty":-4.967839,"median":-4.461387,"eighty":-4.18255,"marketCap":40833429},{"date":"2024-01-12","current":-3.520313,"twenty":-4.949351,"median":-4.397024,"eighty":-4.086666,"marketCap":35553244},{"date":"2024-01-19","current":-3.555168,"twenty":-4.949351,"median":-4.37517,"eighty":-4.043132,"marketCap":35905256},{"date":"2024-01-26","current":-4.217405,"twenty":-4.914497,"median":-4.391678,"eighty":-4.043132,"marketCap":42593490},{"date":"2024-02-02","current":-4.217405,"twenty":-4.914497,"median":-4.356823,"eighty":-4.022309,"marketCap":42593490},{"date":"2024-02-09","current":-4.008626,"twenty":-4.879642,"median":-4.356475,"eighty":-4.008626,"marketCap":40484936},{"date":"2024-02-16","current":-3.79915,"twenty":-4.877446,"median":-4.314662,"eighty":-4.008277,"marketCap":38369342},{"date":"2024-02-23","current":-4.421106,"twenty":-4.852108,"median":-4.351551,"eighty":-4.008277,"marketCap":36976978},{"date":"2024-03-01","current":-4.46488,"twenty":-4.845774,"median":-4.356823,"eighty":-4.008556,"marketCap":37343087},{"date":"2024-03-08","current":-4.683308,"twenty":-4.845774,"median":-4.37517,"eighty":-4.008626,"marketCap":39169969},{"date":"2024-03-15","current":-4.508653,"twenty":-4.845774,"median":-4.391678,"eighty":-4.019572,"marketCap":37709196},{"date":"2024-03-22","current":-4.727519,"twenty":-4.845774,"median":-4.421106,"eighty":-4.038967,"marketCap":39539739},{"date":"2024-03-28","current":-5.471666,"twenty":-4.878324,"median":-4.421106,"eighty":-4.043132,"marketCap":45763587},{"date":"2024-04-05","current":-4.990159,"twenty":-4.946386,"median":-4.434042,"eighty":-4.068645,"marketCap":41736391},{"date":"2024-04-12","current":-4.771293,"twenty":-4.947572,"median":-4.461387,"eighty":-4.088693,"marketCap":39905848},{"date":"2024-04-19","current":-4.508653,"twenty":-4.946386,"median":-4.46488,"eighty":-4.106683,"marketCap":37709196},{"date":"2024-04-26","current":-4.552426,"twenty":-4.946123,"median":-4.508653,"eighty":-4.135548,"marketCap":38075304},{"date":"2024-05-03","current":-4.604954,"twenty":-4.927077,"median":-4.543309,"eighty":-4.168608,"marketCap":38514635},{"date":"2024-05-10","current":-4.683746,"twenty":-4.914497,"median":-4.525981,"eighty":-4.18255,"marketCap":39173630},{"date":"2024-05-17","current":-6.309978,"twenty":-4.927077,"median":-4.552426,"eighty":-4.18255,"marketCap":38441413},{"date":"2024-05-24","current":-6.009503,"twenty":-4.949351,"median":-4.552645,"eighty":-4.18255,"marketCap":36610870},{"date":"2024-05-31","current":-5.254478,"twenty":-5.016423,"median":-4.56334,"eighty":-4.196492,"marketCap":32011137},{"date":"2024-06-07","current":-5.573329,"twenty":-5.126143,"median":-4.595762,"eighty":-4.217405,"marketCap":33953631},{"date":"2024-06-14","current":-5.672448,"twenty":-5.245388,"median":-4.604954,"eighty":-4.217405,"marketCap":34557478},{"date":"2024-06-21","current":-5.254478,"twenty":-5.254478,"median":-4.639973,"eighty":-4.217405,"marketCap":32011137},{"date":"2024-06-28","current":-5.553028,"twenty":-5.257507,"median":-4.639973,"eighty":-4.217405,"marketCap":33829952},{"date":"2024-07-05","current":-6.836793,"twenty":-5.380881,"median":-4.661859,"eighty":-4.222726,"marketCap":41650855},{"date":"2024-07-12","current":-8.120557,"twenty":-5.46684,"median":-4.674942,"eighty":-4.245731,"marketCap":49471758},{"date":"2024-07-15","current":-8.478817,"twenty":-5.484657,"median":-4.679369,"eighty":-4.24745,"marketCap":51654336},{"date":"2024-08-02","current":-10.568666,"twenty":-5.500483,"median":-4.681339,"eighty":-4.24917,"marketCap":64386038},{"date":"2024-08-09","current":-8.299687,"twenty":-5.526159,"median":-4.683746,"eighty":-4.266453,"marketCap":50563047},{"date":"2024-08-16","current":-8.419107,"twenty":-5.589093,"median":-4.694558,"eighty":-4.282332,"marketCap":51290573},{"date":"2024-08-23","current":-7.881717,"twenty":-5.717813,"median":-4.727519,"eighty":-4.286974,"marketCap":48016706},{"date":"2024-08-30","current":-6.896503,"twenty":-6.017985,"median":-4.738462,"eighty":-4.287114,"marketCap":42014618},{"date":"2024-09-06","current":-6.329258,"twenty":-6.201587,"median":-4.792698,"eighty":-4.288183,"marketCap":38558870},{"date":"2024-09-13","current":-7.045778,"twenty":-6.309738,"median":-4.815066,"eighty":-4.296814,"marketCap":42924025},{"date":"2024-09-20","current":-5.76261,"twenty":-6.309738,"median":-4.815066,"eighty":-4.313201,"marketCap":35106760},{"date":"2024-09-27","current":-5.791271,"twenty":-6.293445,"median":-4.845774,"eighty":-4.331833,"marketCap":35281366},{"date":"2024-10-04","current":-5.494176,"twenty":-6.293445,"median":-4.868142,"eighty":-4.350567,"marketCap":40171894},{"date":"2024-10-11","current":-4.148845,"twenty":-6.216784,"median":-4.858839,"eighty":-4.350567,"marketCap":30335209},{"date":"2024-10-18","current":-4.157755,"twenty":-6.122441,"median":-4.845774,"eighty":-4.288183,"marketCap":30400352},{"date":"2024-10-25","current":-4.212202,"twenty":-6.099645,"median":-4.815066,"eighty":-4.286905,"marketCap":30798452},{"date":"2024-10-31","current":-4.032032,"twenty":-6.085858,"median":-4.815066,"eighty":-4.286835,"marketCap":29481103},{"date":"2024-11-08","current":-3.964716,"twenty":-6.030708,"median":-4.792698,"eighty":-4.245731,"marketCap":28988907},{"date":"2024-11-15","current":-4.157755,"twenty":-6.026467,"median":-4.727519,"eighty":-4.217405,"marketCap":30400352},{"date":"2024-11-22","current":-3.652759,"twenty":-6.001802,"median":-4.723303,"eighty":-4.18255,"marketCap":32209897},{"date":"2024-11-29","current":-4.656782,"twenty":-5.970998,"median":-4.694558,"eighty":-4.18255,"marketCap":41063331},{"date":"2024-12-06","current":-5.005528,"twenty":-5.961427,"median":-4.719087,"eighty":-4.18255,"marketCap":44138559},{"date":"2024-12-13","current":-5.066661,"twenty":-5.907942,"median":-4.727519,"eighty":-4.18255,"marketCap":44677628},{"date":"2024-12-20","current":-4.513181,"twenty":-5.895445,"median":-4.727519,"eighty":-4.18255,"marketCap":39797061},{"date":"2024-12-27","current":-4.800383,"twenty":-5.891211,"median":-4.759354,"eighty":-4.202312,"marketCap":42329601},{"date":"2025-01-03","current":-4.595649,"twenty":-5.831182,"median":-4.759354,"eighty":-4.210222,"marketCap":40524262},{"date":"2025-01-10","current":-4.55421,"twenty":-5.791868,"median":-4.759354,"eighty":-4.214283,"marketCap":40158853},{"date":"2025-01-17","current":-4.808589,"twenty":-5.791868,"median":-4.765324,"eighty":-4.217405,"marketCap":42401960},{"date":"2025-01-24","current":-4.841412,"twenty":-5.791749,"median":-4.765324,"eighty":-4.217405,"marketCap":42691393},{"date":"2025-01-31","current":-4.595239,"twenty":-5.790189,"median":-4.759354,"eighty":-4.217405,"marketCap":40520644},{"date":"2025-02-07","current":-4.718325,"twenty":-5.781211,"median":-4.75438,"eighty":-4.222726,"marketCap":41606019},{"date":"2025-02-14","current":-4.636268,"twenty":-5.75842,"median":-4.727519,"eighty":-4.245731,"marketCap":40882436},{"date":"2025-02-21","current":-6.113309,"twenty":-5.785861,"median":-4.749406,"eighty":-4.252608,"marketCap":53906929},{"date":"2025-02-28","current":-3.938776,"twenty":-5.785861,"median":-4.75438,"eighty":-4.252608,"marketCap":34731981},{"date":"2025-03-07","current":-4.061863,"twenty":-5.76261,"median":-4.727519,"eighty":-4.217405,"marketCap":35817355},{"date":"2025-03-14","current":-4.184949,"twenty":-5.741662,"median":-4.718911,"eighty":-4.212202,"marketCap":36902729},{"date":"2025-03-21","current":-3.781635,"twenty":-5.692164,"median":-4.717095,"eighty":-4.184949,"marketCap":33346319},{"date":"2025-03-28","current":-3.800136,"twenty":-5.672448,"median":-4.683746,"eighty":-4.18255,"marketCap":33646606},{"date":"2025-04-04","current":-3.839558,"twenty":-5.66199,"median":-4.683746,"eighty":-4.157755,"marketCap":33995653},{"date":"2025-04-11","current":-3.717019,"twenty":-5.653341,"median":-4.678332,"eighty":-4.145266,"marketCap":32910685},{"date":"2025-04-17","current":-3.41639,"twenty":-5.652863,"median":-4.673905,"eighty":-4.117991,"marketCap":30248898},{"date":"2025-04-24","current":-4.16592,"twenty":-5.633675,"median":-4.661859,"eighty":-4.103527,"marketCap":36885284}],"updateTime":1745595622272}}}